Hepatitis A is a viral infection which can cause severe liver disease. The viral infection is usually spread by contaminated food and water.
Travellers will receive an active vaccine. This is a purified, inactivated preparation of hepatitis A virus.
Those travelling to or who will be residing in areas where the disease is common, particularly if sanitation and food hygiene is likely to be poor. Additional vaccine information: The vaccine is also available combined with hepatitis B or typhoid.
A single injection 2 weeks prior to travel. Then a reinforcing dose 6-12 months later.
General issues: Patients who have had a serious reaction (”anaphylaxis”) to a previous dose of this vaccine or its constituents. Specific issues: One brand of vaccine ”Epaxal” should not be given to those who have had anaphylaxis to hens’ eggs.
There is no evidence of risk.
Very few. Temporary tenderness at the site of the injection.